[Development of immunoassay for cytokines and its clinical significance].

Rinsho Byori

Cellular Technology Institute, Otsuka Pharmaceutical Co. Ltd., Tokushima.

Published: August 1994

As measurement systems of cytokines have recently been developed, there are many reports indicating the relationship between cytokines and various diseases. We have also developed various new measurement systems using gene technology and hybridoma technology. The measurement system is composed of the following 5 steps. (1) Cloning of cytokines, (2) Expression of cytokines, (3) Purification of cytokines, (4) Preparation of antibodies (monoclonal and polyclonal antibodies), (5) Development of immunoassay. Cytokines are measured not only in the cytokine itself but also in the receptor, receptor antagonist, and autoantibody. We established the measurement system of cytokines using ELISA (antibody is labeled by enzyme.) for the cytokine itself and RIA (antigen is labeled by isotope.) for the autoantibody to cytokines. The blood concentration of cytokines is low because cytokines are utilized immediately after production and excreted into the urine. Therefore, the immunological responses of individuals can be determined by an ex vivo measurement of the production of cytokines by stimulation of whole blood with LPS not by simply measuring the cytokine itself in plasma. We call this method "Whole Blood Induction Method". This method is positioned as one of the methods which shows the immunological response of cytokines to the outer body at the time of infection using a low volume of human blood. Finally, studies of cytokines have been carried out not only in immunological systems but also in hormone systems which are closely related to cytokines. Studies have also expanded to fields which, to date, have not been thought to be related by investigating adherence factors.(ABSTRACT TRUNCATED AT 250 WORDS)

Download full-text PDF

Source

Publication Analysis

Top Keywords

cytokines
15
immunoassay cytokines
8
measurement systems
8
measurement system
8
measurement
5
[development immunoassay
4
cytokines clinical
4
clinical significance]
4
significance] measurement
4
systems
4

Similar Publications

Photobiomodulation Combined With Human Umbilical Cord Mesenchymal Stem Cells Modulates the Polarization of Microglia.

J Biophotonics

January 2025

State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Neuromodulation and Neurorepair, Integrative regeneration laboratory, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Neuroinflammation plays a key role in the development of neurodegenerative diseases, with microglia regulating this process through pro-inflammatory M1 and anti-inflammatory M2 phenotypes. Studies have shown that human umbilical cord mesenchymal stem cells (hUCMSCs) modulate neuroinflammation by secreting anti-inflammatory cytokines. Photobiomodulation (PBM), a non-invasive therapy, has demonstrated significant potential in alleviating neuroinflammation.

View Article and Find Full Text PDF

Leaky and structurally abnormal blood vessels and increased pressure in the tumor interstitium reduce the infiltration of CAR-T cells in solid tumors, including triple-negative breast cancer (TNBC). Furthermore, high burden of tumor cells may cause reduction of infiltrating CAR-T cells and their functional exhaustion. In this study, various effector-to-target (E:T) ratio experiments are established to model the treatment using CAR-T cells in leukemia (high E:T ratio) and solid tumor (low E:T ratio).

View Article and Find Full Text PDF

An on-Demand Oxygen Nano-vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy.

Adv Mater

January 2025

State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute. Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, P. R. China.

Hypoxia severely limits the antitumor immunotherapy for breast cancer. Although efforts to alleviate tumor hypoxia and drug delivery using diverse nanostructures achieve promising results, the creation of a versatile controllable oxygen-releasing nano-platform for co-delivery with immunostimulatory molecules remains a persistent challenge. To address this problem, a versatile oxygen controllable releasing vehicle PFOB@F127@PDA (PFPNPs) is developed, which effectively co-delivered either protein drug lactate oxidase (LOX) or nucleic acids drug unmethylated cytosine-phosphate-guanine oligonucleotide (CpG ODNs).

View Article and Find Full Text PDF

SOCS1 deficiency-crossroads of autoimmunity and autoinflammation-two case reports.

Front Pediatr

January 2025

Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich-Heine-University and University Hospital, Duesseldorf, Germany.

Suppressors of cytokine signaling (SOCS) proteins play a critical role in regulating immune signaling pathways. Deficiency of SOCS1 leads to various autoimmune pathologies. We present two unrelated patients with distinct clinical manifestations.

View Article and Find Full Text PDF

Background: Parkinson's disease (PD) is characterized by dopaminergic (DA) neuron loss, Lewy body build-up, and motor dysfunction. One of the primary pathogenic mechanisms of PD development is autophagy dysfunction and nitric oxide-mediated neurotoxicity.

Purpose: The current study focuses on autophagy and nitric oxide (NO) signaling roles in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated PD mice and their protection by their modulators.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!